Novartis raises full year outlook (1:13)
July 17 - Swiss drug maker Novartis raises its full year outlook as a generic competitor to its blockbuster blood pressure pill Diovan is delayed. Hayley Platt reports. ( Transcript )
Hard-edged reporting, insight and analysis, Reuters TV breaks ground creating informative news and financial videos. Showcasing Reuters’ 3000 award-winning journalists, Reuters TV delivers high-energy investigative journalism with concise explanations. Check it out and let us know what you think.